Biosimilar firms urge EU government action to boost sluggish market
This article was originally published in SRA
Executive Summary
A feeling that biosimilars have still not delivered on their promise despite their years on the market pervaded this year�s annual biosimilars conference held by the European Generic medicines Association (EGA) at the Tower Hotel in London's docklands1.